12/12/2024
5:13 AM | Calidi Biotherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
11/29/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/18/2024
7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
5:03 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/14/2024
5:21 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/12/2024
4:08 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
10/28/2024
9:05 AM | Calidi Biotherapeutics (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/24/2024
4:18 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
8:38 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2024
7:25 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/18/2024
4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
4:29 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
8:14 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2024
4:05 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
09/30/2024
5:53 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
8:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
5:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:12 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
3:04 PM | Calidi Biotherapeutics (Subject)
Funicular Funds, LP (Filed by)
| Form SC 13G | |
08/22/2024
4:16 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
5:04 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
4:10 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024
8:15 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/15/2024
3:58 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
3:51 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2024
3:53 PM | Calidi Biotherapeutics (Issuer)
Peoples George (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
7:20 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:22 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:12 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:14 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:16 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
7:18 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:15 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Jackson Andrew C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
"X-Ray Vision" could find thousands of hidden market opportunities (Ad) Let me show you how I trade with “X-Ray vision.”
You see, most “trend” traders only use one trend filter when looking for an optimal buy signal.
And that can be a big mistake because you can’t see if you’re in a “True Trend.”
But my newest trading tool is designed to only target the best, most stable stocks…
Using 3 trend filters… which are these green, yellow, and red lines. Just tap here to join the presentation. |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Campbell Wendy Pizarro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Minev Boris Radoslavov (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:56 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:15 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/17/2024
3:35 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/14/2024
8:01 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:57 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form DEF 14A | |
05/01/2024
11:57 AM | Calidi Biotherapeutics (Subject)
Kessler Judd S (Filed by)
| Form SCHEDULE 13D | |
04/19/2024
4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
4:20 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/17/2024
3:15 PM | Calidi Biotherapeutics (Filer)
| Form 424B4 | |
04/16/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
04/15/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/08/2024
3:40 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/02/2024
4:29 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/01/2024
8:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
8:47 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
03/18/2024
7:41 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:28 PM | Calidi Biotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/12/2024
7:00 PM | Calidi Biotherapeutics (Issuer)
LaPre David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/12/2024
4:28 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
03/12/2024
3:51 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:27 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
02/14/2024
5:05 AM | Calidi Biotherapeutics (Subject)
First Light Acquisition Group, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:32 PM | Calidi Biotherapeutics (Subject)
First Trust Capital Management L.P. (Filed by)
| Form SC 13G/A | |
02/12/2024
5:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
5:32 AM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
02/09/2024
4:03 PM | Calidi Biotherapeutics (Subject)
SPRING CREEK CAPITAL LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
5:53 AM | Calidi Biotherapeutics (Subject)
Polar Asset Management Partners Inc. (Filed by)
| Form SC 13G/A | |
02/07/2024
12:06 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
11:35 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
02/01/2024
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
4:10 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
01/29/2024
8:32 AM | Calidi Biotherapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/21/2024
11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
01/16/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
01/08/2024
7:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
01/05/2024
7:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:55 PM | Calidi Biotherapeutics (Issuer)
Zulueta Alfonso G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:49 PM | Calidi Biotherapeutics (Issuer)
Camaisa Allan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:49 PM | Calidi Biotherapeutics (Issuer)
Leftwich Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:51 PM | Calidi Biotherapeutics (Issuer)
Schoeneck James A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
6:52 PM | Calidi Biotherapeutics (Issuer)
Stewart Alan R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:52 PM | Calidi Biotherapeutics (Issuer)
Vecchiolla Thomas A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Healthcare Takes A Big Step Forward With The Help of A.I. (Ad) To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still simple, proof-of-concept systems.
For its next act, AI is going to help save lives.
Already better than humans at a number of medical tasks, AI is ramping up to completely revolutionize healthcare. Click here to learn more about the booming eHealth industry - and see which microcap will be at the |
12/19/2023
4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
